Current affiliation: Kanazawa University School of MedicineSubject: Medicine And Medical SciencesPrimary location: Japan
Published in:Thrombosis ResearchPublication date:2014-03-01
TM is an ideal treatment for patients with DIC based upon hematologic malignancy.
Published in:Journal of Intensive CarePublication date:2014-01-01
DIC with suppressed fibrinolysis, DIC with enhanced fibrinolysis and DIC with balanced fibrinolysis.
Published in:Clinical Interventions in AgingPublication date:2016-08-01